Serum antioxidant levels in patients during chemotherapy

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2011, Vol 28, Issue 2

Abstract

OBJECTIVE Chemotherapy results of increase in free radical formation and depletion of tissue antioxidants. It has also been claimed that antioxidants can increase the effectiveness of cytotoxic therapy and their use during chemotherapy has been recommended, although some clinicians advise their patients against the use of antioxidant dietary supplements during chemotherapy, suggesting that they could be harmful the therapy. The aims of this study were to determine the antioxidant status of patients during chemotherapy and its correlation with sex and with frequency of administration of the chemotherapy. METHOD Serum trolox equivalent antioxidant capacity (TAC) was measured in 51 patients (16 male and 35 female) during chemotherapy. 17 patients were receiving their therapy once a week and 34 daily. Antioxidant activity was estimated by the effect of serum on the oxidation of 2.2'-azino-bis(3-ethylbenthiazoline)-6-sulfonic acid by the ferryl myoglobin-H2O2 system. Trolox, the water soluble analogue of vitamin E, was used as the control. The antioxidant concentration was expressed as trolox equivalents. RESULTS-CONCLUSIONS A significant decrease in serum TAC was observed in all the patients during chemotherapy (by a mean of 67.3% decrease compared to normal levels, p=0.001). There was also a differentiation in serum TAC related to both sex and the frequency of chemotherapy: Lower serum TAC levels were detected in male patients, and in patients receiving chemotherapeutic drugs daily, compared to those receiving chemotherapy once a week.

Authors and Affiliations

E. LIMBERAKI, P. ELEFTHERIOU, G. GASPARIS, C. PETROU

Keywords

Related Articles

HAIR-AN syndrome

No abstract available

Elucidation of cytomegalovirus infection and recurrence in a HIV-1(+) patient

This study illustrates the power of molecular biology techniques based on PCR in the elucidation of cytomegalovirus (CMV) infection in a ÇÉV-1(+) patient. CMV is responsible for the most common viral opportunistic inf...

Healing environment and evidence-based design (EBD): The international experience and the case of Greece

The physical environment of a hospital affects the safety and well being of patients, visitors and staff, and the quality and costs of the services provided. In addition there is a strong relationship between the structu...

Ηepatic hydrothorax in a ΗCV-positive patient with liver cirrhosis Case report and literature review

Hepatic hydrothorax (HH) is an uncommon complication of portal hypertension. The disorder is defined as the presence of transudative pleural effusion in a patient with liver cirrhosis and no primary pulmonary or cardiac...

Download PDF file
  • EP ID EP124240
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

E. LIMBERAKI, P. ELEFTHERIOU, G. GASPARIS, C. PETROU (2011). Serum antioxidant levels in patients during chemotherapy. Αρχεία Ελληνικής Ιατρικής, 28(2), 251-256. https://europub.co.uk/articles/-A-124240